menu
    • menu

    Company profile for Biogen

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 1978 by a small group of visionary scientists, Biogen helped pioneer the biotechnology industry. Today, we are one of the oldest independent biotechnology companies in the world. For close to four decades, hundreds of thousands of people around the world living with serious illnesses have benefited from innovative and important medicines developed by the people of Biogen. We are proud of the role we have played in a...
    Founded in 1978 by a small group of visionary scientists, Biogen helped pioneer the biotechnology industry. Today, we are one of the oldest independent biotechnology companies in the world. For close to four decades, hundreds of thousands of people around the world living with serious illnesses have benefited from innovative and important medicines developed by the people of Biogen. We are proud of the role we have played in advancing the field of biotechnology and helping patients — and are building on this legacy of great science and discovery as we pursue increasingly complex challenges.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BiogenUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    225 Binney Street Cambridge, MA 02142
    Telephone
    Telephone
    +1 781-464-2000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biogen.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/biogen-/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/biogen

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Stoke, Biogen Unveil Zorevunersen Data Syndrome for Dravet at AES
    Stoke, Biogen Unveil Zorevunersen Data Syndrome for Dravet at AES

    05 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-05/stoke-therapeutics-and-biogen-present-data-that-further-support-the-disease-modifying-potential-of-z

    PHARMIWEB
    05 Dec 2025
    Share Share
    Eisai Reveals Extended Benefits Of LEQEMBI In Early Alzheimer
    Eisai Reveals Extended Benefits Of LEQEMBI In Early Alzheimer

    03 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/03/3199431/0/en/Eisai-Presents-New-Data-on-the-Continued-and-Expanding-Benefit-of-LEQEMBI-lecanemab-irmb-Maintenance-Treatment-in-Early-Alzheimer-s-Disease-at-the-Clinical-Trials-on-Alzheimer-s-Di.html

    GLOBENEWSWIRE
    03 Dec 2025
    Share Share
    Biogen, Stoke Announce Presentations at 2025 AES Annual Meeting
    Biogen, Stoke Announce Presentations at 2025 AES Annual Meeting

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3196905/0/en/Biogen-and-Stoke-Therapeutics-Announce-Presentations-at-the-2025-American-Epilepsy-Society-Annual-Meeting.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Eisai Files NDA for Subcutaneous LEQEMBI in Early AD in Japan
    Eisai Files NDA for Subcutaneous LEQEMBI in Early AD in Japan

    27 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/28/3195968/0/en/Eisai-Submits-New-Drug-Application-for-Subcutaneous-Formulation-of-LEQEMBI-for-the-Treatment-of-Early-Alzheimer-s-Disease-in-Japan.html

    GLOBENEWSWIRE
    27 Nov 2025
    Share Share
    Biogen & Dayra Partner On Oral Macrocyclic Peptide Discovery
    Biogen & Dayra Partner On Oral Macrocyclic Peptide Discovery

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193394/0/en/Biogen-and-Dayra-Therapeutics-Announce-Research-Collaboration-to-Discover-and-Develop-Oral-Macrocyclic-Peptides-for-a-Range-of-Immunological-Conditions.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share
    Eisai Files sBLA with FDA for LEQEMBI in Early Alzheimer Diseases
    Eisai Files sBLA with FDA for LEQEMBI in Early Alzheimer Diseases

    25 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eisai-completes-rolling-submission-to-us-fda-for-leqembi-iqlik-lecanemab-irmb-supplemental-biologics-license-application-as-a-subcutaneous-starting-dose-for-the-treatment-of-early-alzheimers-disease-under-fast-track-status-302625100.html

    PR NEWSWIRE
    25 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Biogen and get a quotation

    Biogen is a supplier offers 3 products (APIs, Excipients or Intermediates).

    Find a price of MURINE MONOCLONAL ANTIBODY (2B8) TO CD20 bulk offered by Biogen

    Find a price of HUMANIZED MONOCLONAL ANTIBODY (IDEC-131) (CHO CELLS, IDEC) TO CD40L (CD 154) bulk offered by Biogen

    Find a price of IDEC-114 (GALIXIMAB);CHEMERIC (MACAQUE/HUMAN) MONOCLONAL ANTIBODY TO CD80 (B7.1) bulk offered by Biogen

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search